Literature DB >> 11566518

Topical anesthesia with or without propofol sedation versus retrobulbar/peribulbar anesthesia for cataract extraction: prospective randomized trial.

H Kallio1, R J Uusitalo, E L Maunuksela.   

Abstract

PURPOSE: To evaluate the feasibility of intravenous sedation in addition to topical anesthesia during cataract extraction.
SETTING: Helsinki University Eye Hospital, Helsinki, Finland.
METHODS: Three hundred seventeen eyes of 291 consecutive patients having cataract surgery were prospectively randomized to receive topical (oxybuprocaine 0.4%, n = 96), combined (topical anesthesia and propofol sedation, n = 107), or retrobulbar/peribulbar (prilocaine 1.5%, n = 114) anesthesia. The intraoperative conditions were judged by the surgeon. A numerical scale (0 to 10) was used to assess the degree of pain during surgery. Outcome measures were the number of complications and adverse events registered perioperatively and 1 week postoperatively as well as Snellen visual acuity.
RESULTS: The success of posterior chamber intraocular lens (IOL) implantation through a self-sealing clear corneal incision was 97.9%, 96.3%, and 98.2% in the topical, combined, and retrobulbar/peribulbar groups, respectively. There was no difference among the groups in pain during surgery, frequency of complications, or outcome measures. One week postoperatively, visual acuity was 20/40 or better in 81.7%, 78.5%, and 77.5% of eyes in the topical, combined, and retrobulbar/peribulbar groups, respectively. The surgeon reported significantly fewer difficulties in the retrobulbar/peribulbar group (9.8%) than in the topical (26.0%) (P =.004) or combined (21.0%) (P =.036) groups. Additional sedative/analgesic medication given intraoperatively was required significantly more often in the topical (15.6%) than in the retrobulbar/peribulbar group (2.6%) (P =.002). Patients with bilateral surgery preferred combined anesthesia over retrobulbar/peribulbar anesthesia; however, there was no significant difference in patient acceptance among groups in patients having unilateral surgery.
CONCLUSION: Intravenous propofol sedation added to topical anesthesia did not improve the operative conditions or surgical outcome. Retrobulbar/peribulbar anesthesia ensured the best surgical conditions. Patients in all anesthesia groups reported high satisfaction. However, patients having bilateral surgery seemed to prefer combined anesthesia over retrobulbar/peribulbar anesthesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11566518     DOI: 10.1016/s0886-3350(01)00800-8

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

1.  Short term general anesthesia for retro-bulbar block in ophthalmic surgery generates no significant hypercapnia.

Authors:  Werner Baulig; Monica Weber; Beatrice Beck-Schimmer; Oliver M Theusinger; Peter Biro
Journal:  J Clin Monit Comput       Date:  2017-03-11       Impact factor: 2.502

2.  Safety and efficacy of fentanyl versus pethidine in cataract surgery under propofol- based sedation: A double-blind randomized controlled clinical trial.

Authors:  Hamidreza Shetabi; Seyed Jalal Hashemi; Fariba Haghi; Dariush Moradi Farsani
Journal:  J Res Med Sci       Date:  2020-08-24       Impact factor: 1.852

3.  Comparison of clinical outcomes, patient, and surgeon satisfaction following topical versus peribulbar anesthesia for phacoemulsification and intraocular lens implantation: a randomized, controlled trial.

Authors:  Kuldeep Dole; Sucheta Kulkarni; Kavita D Shisode; Rahul Deshpande; Nilesh Kakade; Rajiv Khandekar; Madan Deshpande
Journal:  Indian J Ophthalmol       Date:  2014-09       Impact factor: 1.848

4.  The effect of post-traumatic-stress-disorder on intra-operative analgesia in a veteran population during cataract procedures carried out using retrobulbar or topical anesthesia: a retrospective study.

Authors:  Yuna Rapoport; Laura L Wayman; Amy S Chomsky
Journal:  BMC Ophthalmol       Date:  2017-06-07       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.